DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma-Reference-Cited by-同舟云学术

DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma

Published:2013-11-08 Issue:11 Volume:8 Page:e79526
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Berger Alice H.,Chen Ming,Morotti Alessandro,Janas Justyna A.,Niki Masaru,Bronson Roderick T.,Taylor Barry S.,Ladanyi Marc,Van Aelst Linda,Politi Katerina,Varmus Harold E.,Pandolfi Pier Paolo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing;M Imielinski;Cell,2012

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;JG Paez;Science,2004

3. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib;W Pao;Proc Natl Acad Sci U S A,2004

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;TJ Lynch;N Engl J Med,2004

5. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants;H Greulich;PLOS Med,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome‐level Asian elephant genome assembly and comparative genomics of long‐lived mammals reveal the common substitutions for cancer resistance;Aging Cell;2023-07-03

2. Genome-Wide Population Structure and Selection Signatures of Yunling Goat Based on RAD-seq;Animals;2022-09-13

3. Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer;Cells;2021-12-16

4. Introduction to DOK2 and its Potential Role in Cancer;Physiological Research;2021-10-31

5. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma;PeerJ;2020-07-23